Department of Endocrinology, Odense University Hospital, Kloevervaenget 6. Odense, Denmark.
J Bone Miner Res. 2012 Jun;27(6):1405-12. doi: 10.1002/jbmr.1592.
Osteogenesis imperfecta (OI) is a hereditary disorder characterized by decreased biosynthesis or impaired morphology of type I collagen that leads to decreased bone mass and increased bone fragility. We hypothesized that patients with OI have altered bone microstructure and bone geometry. In this cross-sectional study we compared patients with type I OI to age- and gender-matched healthy controls. A total of 39 (13 men and 26 women) patients with OI, aged 53 (range, 21-77) years, and 39 controls, aged 53 (range, 21-77) years, were included in the study. Twenty-seven of the patients had been treated with bisphosphonates. High-resolution peripheral quantitative computed tomography (HR-pQCT) at the distal radius and distal tibia and dual-energy X-ray absorptiometry of total hip, femoral neck, trochanteric region, and the lumbar spine (L1-L4) were performed. The patients were shorter than the controls (159 ± 10 cm versus 170 ± 9 cm, p < 0.001), but had similar body weight. In OI, areal bone mineral density (aBMD) was 8% lower at the hip (p < 0.05) and 13% lower at the spine (p < 0.001) compared with controls. The trabecular volumetric bone mineral density (vBMD) was 28% lower in radius (p < 0.001) and 38% lower in tibia (p < 0.001) in OI compared with controls. At radius, total bone area was 5% lower in OI than in controls (p < 0.05). In the tibia, cortical bone area was 18% lower in OI (p < 0.001). In both radius and tibia the number of trabeculae was lower in patients compared to the controls (35% and 38%, respectively, p < 0.001 at both sites). Furthermore, trabecular spacing was 55% higher in OI in both tibia and radius (p < 0.001 at both sites) when compared with controls. We conclude that patients with type I OI have lower aBMD, vBMD, bone area, and trabecular number when compared with healthy age- and gender-matched controls.
成骨不全症(OI)是一种遗传性疾病,其特征是 I 型胶原的生物合成减少或形态受损,导致骨量减少和骨脆性增加。我们假设 OI 患者的骨微观结构和骨几何形状发生了改变。在这项横断面研究中,我们将 I 型 OI 患者与年龄和性别匹配的健康对照组进行了比较。共有 39 名(13 名男性和 26 名女性)OI 患者,年龄 53 岁(范围 21-77 岁),39 名对照组,年龄 53 岁(范围 21-77 岁)。27 名患者接受了双膦酸盐治疗。在桡骨远端和胫骨远端进行高分辨率外周定量计算机断层扫描(HR-pQCT),并对全髋关节、股骨颈、转子区和腰椎(L1-L4)进行双能 X 射线吸收法测量。患者的身高比对照组矮(159±10cm 比 170±9cm,p<0.001),但体重相似。与对照组相比,OI 患者髋关节的骨矿密度(aBMD)低 8%(p<0.05),脊柱的 aBMD 低 13%(p<0.001)。与对照组相比,OI 患者桡骨的骨小梁体积骨密度(vBMD)低 28%(p<0.001),胫骨的 vBMD 低 38%(p<0.001)。与对照组相比,桡骨的总骨面积低 5%(p<0.05)。胫骨的皮质骨面积低 18%(p<0.001)。与对照组相比,患者的骨小梁数量在桡骨和胫骨中均较低(分别低 35%和 38%,p<0.001)。此外,与对照组相比,桡骨和胫骨的骨小梁间距均增加 55%(p<0.001)。综上所述,与年龄和性别匹配的健康对照组相比,I 型 OI 患者的 aBMD、vBMD、骨面积和骨小梁数量均较低。